BIIB : Summary for Biogen Inc. - Yahoo Finance

U.S. Markets closed

Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
271.21-5.36 (-1.94%)
At close: 4:00PM EDT
People also watch
CELGGILDREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close276.57
Open277.09
Bid262.00 x 100
Ask272.29 x 200
Day's Range271.08 - 277.28
52 Week Range223.02 - 333.65
Volume1,647,477
Avg. Volume1,657,751
Market Cap58.57B
Beta0.51
PE Ratio (TTM)16.02
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube13 hours ago

    ETFs with exposure to Biogen, Inc. : April 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Biogen, Inc. Here are 5 ETFs with the largest exposure to BIIB-US. Comparing the performance and risk of Biogen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • What's Worrying Me About Biogen
    Motley Fool14 hours ago

    What's Worrying Me About Biogen

    Biogen could struggle to maintain its market-leading position in multiple sclerosis over the next two years.

  • Market Realist18 hours ago

    Biogen Has Developed a Robust Access Strategy for Spinraza

    In 1Q17, Biogen’s (BIIB) Spinraza earned revenues of $47.0 million, of which $46.0 million were from the US market.